Background: In September 2011, Malawi implemented Option B+ (B+), lifelong antiretroviral therapy (ART) for pregnant and breast feeding women. The Tingathe program, started in 2009, two years prior to B+, is a service program utilizing dedicated community health workers (CHWs) as case managers to improve uptake and retention along the PMTCT cascade. The service is offered as part of routine care at participating government health centers. We assessed the impact of B+ on service uptake, retention, and vertical HIV transmission by comparing outcomes pre and post B+ implementation at 2 health centers in Lilongwe. Methodology: PMTCT service utilization, program retention, and transmission outcomes at 1st DNA PCR (4-20 wks of age) were compared for HIVinfected (HIV+) pregnant women and their exposed infants followed in Tingathe 18 months pre (Oct 2009-Mar 2011) and post (Oct 2011-Mar 2013) B+. Chi-square and Fisher’s exact test as well as two-sample t-test were used to compare proportions of events and continuous variables, respectively. Results: A total of 13,926 (pre) and 14,022 (post) women presented to antenatal care. Post B+ a smaller proportion of women were HIV tested (98.9% pre vs 83.4% post; p<0.001); attributed to test kit stock-outs. There were 1654 (pre) and 1535 (post) HIV+ women identified, with a larger proportion already known to be HIV+ (18.1% vs 41.2%; p<0.001) and an increase in the proportion of women already on ART post B+ (22.8% vs 31.1%; p<0.001). Of those starting ART, mean time to ART initiation (38 } 32 vs 19.7 } 47 days; p<0.001) and duration on ART prior to delivery (69 } 43 vs 93 } 46.5 days; p<0.001) improved significantly. Amongst recorded live births there was no change in proportion of women (95.6% vs 96.3%; p=0.45) and infants receiving antiretrovirals for PMTCT (96.3% vs 95.3%; p=0.11) nor infants receiving 1st DNA PCR (80.9% vs 82%; p=0.55). However, other outcomes suggest improvements in infant care post B+: mean age at 1st DNA PCR (70 } 45 pre vs 57 } 31 days post; p<0.001) and transmission at 1st DNA PCR was lower Background: In September 2011, Malawi implemented Option B+ (B+), lifelong antiretroviral therapy (ART) for pregnant and breast feeding women. The Tingathe program, started in 2009, two years prior to B+, is a service program utilizing dedicated community health workers (CHWs) as case managers to improve uptake and retention along the PMTCT cascade. The service is offered as part of routine care at participating government health centers. We assessed the impact of B+ on service uptake, retention, and vertical HIV transmission by comparing outcomes pre and post B+ implementation at 2 health centers in Lilongwe. Methodology: PMTCT service utilization, program retention, and transmission outcomes at 1st DNA PCR (4-20 wks of age) were compared for HIVinfected (HIV+) pregnant women and their exposed infants followed in Tingathe 18 months pre (Oct 2009-Mar 2011) and post (Oct 2011-Mar 2013) B+. Chi-square and Fisher’s exact test as well as two-sample t-test were used to compare proportions of events and continuous variables, respectively. Results: A total of 13,926 (pre) and 14,022 (post) women presented to antenatal care. Post B+ a smaller proportion of women were HIV tested (98.9% pre vs 83.4% post; p<0.001); attributed to test kit stock-outs. There were 1654 (pre) and 1535 (post) HIV+ women identified, with a larger proportion already known to be HIV+ (18.1% vs 41.2%; p<0.001) and an increase in the proportion of women already on ART post B+ (22.8% vs 31.1%; p<0.001). Of those starting ART, mean time to ART initiation (38 } 32 vs 19.7 } 47 days; p<0.001) and duration on ART prior to delivery (69 } 43 vs 93 } 46.5 days; p<0.001) improved significantly. Amongst recorded live births there was no change in proportion of women (95.6% vs 96.3%; p=0.45) and infants receiving antiretrovirals for PMTCT (96.3% vs 95.3%; p=0.11) nor infants receiving 1st DNA PCR (80.9% vs 82%; p=0.55). However, other outcomes suggest improvements in infant care post B+: mean age at 1st DNA PCR (70 } 45 pre vs 57 } 31 days post; p<0.001) and transmission at 1st DNA PCR was lower (4.6% pre vs 2.6% post; p=0.046); proportion of HIV+ infants starting ART was greater (78.1% vs 90%; p=0.45); mean age at initiation was lower (171 } 88 vs 118 } 76 days; p=0.046). Conclusions: Patient level data from a CHW supported program in Lilongwe, Malawi demonstrate that B+’s simplified PMTCT approach has resulted in several improvements including improved ART use during pregnancy and more rapid initiation with longer duration of coverage for those newly initiating. Early findings suggest concomitant improvements in infant care along the cascade. Health systems issues like timely and reliable HIV testing for women and infants, continue to greatly impact implementation and will need to be addressed to ensure an AIDS-free generation.